Cytokine gene polymorphisms in the Dutch population
N Skorpil1, L Kolesár, I Striz
1Department of Immunology, Faculty of Medicine, Free University of Amsterdam, The Netherlands. nsL300@student.vu.nl
International Journal of Immunogenetics
|March 22, 2007
Summary
Cytokine gene polymorphisms influence disease susceptibility and transplant outcomes. Dutch population genetic data revealed significant differences in five single nucleotide polymorphisms (SNPs) compared to Italians, but not Czechs.
Area of Science:
- Immunogenetics
- Human Genetics
- Population Genetics
Background:
- Cytokine production and activity variations impact infectious diseases, autoimmune disorders, cancer, and transplant rejection.
- Individual differences in cytokine production are frequently linked to single nucleotide polymorphisms (SNPs) in cytokine genes.
Purpose of the Study:
- To analyze cytokine gene polymorphisms in a Dutch Caucasian population.
- To compare these polymorphisms with existing data from Czech and Italian populations.
- To assess the potential clinical utility of this genetic information.
Main Methods:
- Genotyping of 22 SNPs across 13 cytokine genes in 107 Dutch individuals.
- Estimation of allele frequencies using direct gene counting.
- Hardy-Weinberg equilibrium testing.
- Comparison of allele frequencies between Dutch, Czech, and Italian populations.
Main Results:
- Five SNPs showed significant allele frequency differences between the Dutch and Italian populations.
- No significant differences in these five SNPs were observed between the Dutch and Czech populations.
- Allele frequencies for 22 SNPs in 13 cytokine genes were determined for the Dutch population.
Conclusions:
- Cytokine gene SNP analysis reveals population-specific genetic variations.
- This data can aid in predicting clinical outcomes for infectious and immune-related diseases.
- Genetic profiling may help estimate risks for transplant rejection and graft-versus-host disease.
Related Concept Videos
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
02:32Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...